In this study, we confirmed that TMZ, an alkylating agent for treating brain cancer, especially glioblastoma [2,3,26], causes depressant- and anxiety-like behavior, but it also decreased the number of Ki67 and DCX cells in rodents [8]. This evidence concerns the gene MKI67 and glioblastoma.